Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 157.50
Bid: 150.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 15.00 (10.00%)
Open: 157.50
High: 157.50
Low: 157.50
Prev. Close: 157.50
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Jul 2022 07:00

RNS Number : 2575S
Itaconix PLC
13 July 2022
 

13 July 2022

 

Itaconix plc

("Itaconix" or the "Company")

Trading Update

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products, is pleased to provide a trading update for the half year to 30 June 2022.

The Company produced record unaudited revenues of $3.0 million for the first six months of the year. These revenues reflect 124% growth over the first half of 2021 and 149% growth from the second half of 2021. In addition, they are 118% of the full year revenues for 2021 and 93% of the full year revenues for 2020. The Company is in a strong position to meet market expectations for revenues in 2022.

Cleaning applications led overall revenue growth for the period with a 212% increase over the first half of 2021 as Itaconix polymers found important new usage in European detergent formulations and continued to gain share in North America. The Company had strong volumes throughout the first six months and is starting the second half with a solid order book. 

These gains were offset by lower revenues from beauty and hygiene applications in the first half of 2022 compared to the first half of 2021. The Company made good progress with new accounts and usages in both areas, but they were not enough to balance against lower order volumes from partners.

Overall gross profit margin for the first six months was lower than in previous periods due to the mix of product revenues and the timing of passing on higher raw material costs. The Company expects a more favourable blend of product mix and raw material prices in the second half of the year, together with some sales price increases.

Net unaudited cash as at 30 June 2022 was $0.9 million.

John R. Shaw, CEO of Itaconix, commented:

"Engagement with customers on decarbonizing everyday products with our innovative ingredients is paying off with a solid base of recurring revenues and a strong pipeline of new revenue opportunities.

"We are seeing increased traction for our plant-based cleaning ingredients as existing customers expand into more retailers and important new customers bring new formulations to market. We expect to see at least one new European detergent product on the market this year, and possibly even more. With these breakthroughs and steady advances in North America, we expect continued progress through in to 2023.

"As the revenues and success of our current products become more certain, we are setting our sights on bigger and broader ingredient opportunities from our proprietary technology platform. We are working with potential customers on new products that they can bring to the hygiene market with our plant-based superabsorbent.

"We are very pleased to see our business progress to this stage, are excited about the opportunities in front of us to grow the Company, and are now in the process of strengthening our Board for our next level of growth."

Capital Markets Webinar

An online Capital Markets webinar was recently held on 6 July 2022 and investors can access the video presentation, which gives more detail on product development and market opportunities, at the following link: www.edisongroup.com/itaconix-capital-markets-day/. The video will also be available shortly in the investor section of Itaconix's website.

 

 

 

- Ends -

 

For further information please contact:

Itaconix plc

+1 603 775 4400

John R. Shaw / Laura Denner

Belvedere Communications

+44 (0) 74 070 23147

John West / Llew Angus

finnCap

+44 (0) 20 7220 0500

Ed Frisby / Abigail Kelly / Milesh Hindocha (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's contributions to the global low carbon economy are recognised by the London Stock Exchange's Green Economy Mark.

www.itaconix.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGGGDRXGBDGDX
Date   Source Headline
16th Mar 20167:00 amRNSDirectorate Change
1st Mar 20168:41 amRNSTotal Voting Rights
25th Jan 20167:00 amRNSRenewed & Expanded Contract
11th Jan 20167:00 amRNSBlocklisting Interim Review
30th Nov 20155:21 pmRNSHolding(s) in Company
30th Nov 20157:00 amRNSTotal Voting Rights
30th Oct 201512:30 pmRNSTotal Voting Rights
21st Sep 20157:00 amRNSInterim Results
18th Sep 20157:00 amRNSDirectorate Change
7th Sep 201512:18 pmRNSTotal Voting Rights
2nd Sep 20157:00 amRNSBlocklisting Interim Review
1st Sep 20157:03 amRNSLicence with OCI Alabama LLC
15th Jun 201512:27 pmRNSHolding(s) in Company
3rd Jun 20157:00 amRNSGlobal licence signed with Solvay
20th May 201512:17 pmRNSResult of AGM
15th May 20151:21 pmRNSHolding(s) in Company
15th May 20151:17 pmRNSHolding(s) in Company
11th May 20157:05 amRNSDirector Declaration
5th May 20157:01 amRNSDirector/PDMR Shareholding
13th Apr 20157:00 amRNSNotice of AGM
30th Mar 20157:00 amRNSPreliminary Results
24th Mar 20157:15 amRNSDirector Declaration
9th Jan 20157:00 amRNSBlocklisting Interim Review
5th Jan 201512:00 pmRNSTotal Voting Rights
11th Dec 20147:00 amRNSHolding(s) in Company
10th Nov 20147:00 amRNSPatent Infringement Settled and Discontinued
10th Oct 20144:22 pmRNSTotal Voting Rights
29th Sep 20147:00 amRNSInterim Results
25th Sep 20147:00 amRNSGlobal licence signed with Solvay
26th Aug 20147:00 amRNSNew CEO start date confirmed
9th Jul 20147:00 amRNSBlocklisting Interim Review
4th Jul 20147:00 amRNSAppointment of Chief Executive Officer
2nd Jul 20147:00 amRNSTotal Voting Rights
23rd Jun 20147:01 amRNSNotification of Major Interest in Shares
23rd Jun 20147:00 amRNSNotification of Major Interest in Shares
9th Jun 20147:00 amRNSUS supply agreement for nicotine chewing gum
3rd Jun 20147:00 amRNSTotal Voting Rights
22nd May 201412:34 pmRNSResult of AGM
30th Apr 20143:16 pmRNSNotification of Major Interest in Shares
24th Apr 20147:00 amRNSAward under Long Term Incentive Plan
23rd Apr 201412:45 pmRNSNotification of Major Interest in Shares
23rd Apr 20147:00 amRNSNotice of AGM
22nd Apr 201411:58 amRNSTotal Voting Rights
14th Apr 20147:00 amRNSAward of Technology Strategy Board funding
31st Mar 20147:00 amRNSPreliminary Results
3rd Mar 20147:00 amRNSTotal Voting Rights
30th Jan 201411:39 amRNSBlock Listing
27th Jan 20147:00 amRNSDirectorate Change
24th Jan 20144:46 pmRNSHolding(s) in Company
10th Jan 20147:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.